Authors: Possinger, K Kaufmann, M Coleman, R Stuart, NSA Helsing, M Ohnmacht, U Arning, M

Citation: K. Possinger et al., Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer, ANTI-CANC D, 10(2), 1999, pp. 155-162